Pre-clinical toxicity of Il-4: A model for studying protein therapeutics

This publication has 10 references indexed in Scilit:

• IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1.
  The Journal of Immunology, 1990
• IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production.
  The Journal of Immunology, 1990
• IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils.
  The Journal of Immunology, 1990
• Lymphokine Control of In Vivo Immunoglobulin Isotype Selection
  Annual Review of Immunology, 1990
• Promotion of human T lymphocyte proliferation by IL-4.
  The Journal of Immunology, 1989
• Therapeutic and Toxic Activity of Tumor Necrosis Factor Is Synergistic with Gamma Interferon
  Pathology and Immunopathology Research, 1989
• Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma.
  The Journal of Experimental Medicine, 1988
• IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
  The Journal of Immunology, 1988
• Interleukin 4/B cell stimulatory factor 1: one lymphokine, many functions ¹
  The FASEB Journal, 1987
• Assessment of the antigenic response in humans to a recombinant mutant interferon beta
  Journal of Clinical Immunology, 1987